Medical Care
Global Genomic and Proteomic Tool Market Research Report 2025
- Jul 08, 25
- ID: 348950
- Pages: 84
- Figures: 87
- Views: 12
The global market for Genomic and Proteomic Tool was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Smart food logistics provider helps FMCG industries to maintain the quality of foods, such as fruits and vegetables, so that it does not spoil. Smart food logistics companies use wireless temperature sensors that help preserve frozen foods and provide multi-zone monitoring in refrigerated trucks and trailers.
North American market for Genomic and Proteomic Tool is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Genomic and Proteomic Tool is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Genomic and Proteomic Tool in Research Labs and Institutes is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Genomic and Proteomic Tool include 3billion, Inc., Bio-Rad Laboratories, Inc., Lucigen Corp., Macrogen, Inc., Abbott, Thermal Fisher Scientific, Inc., Bio-Synthesis, Inc., GE Healthcare, QIAGEN NV, Novogene Corp., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Genomic and Proteomic Tool, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genomic and Proteomic Tool.
The Genomic and Proteomic Tool market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Genomic and Proteomic Tool market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genomic and Proteomic Tool companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
3billion, Inc.
Bio-Rad Laboratories, Inc.
Lucigen Corp.
Macrogen, Inc.
Abbott
Thermal Fisher Scientific, Inc.
Bio-Synthesis, Inc.
GE Healthcare
QIAGEN NV
Novogene Corp.
Waters Corp.
OriGene Technologies
Takara Bio, Inc.
Vela Diagnostics
Segment by Type
Genomics
Proteomics
Segment by Application
Research Labs and Institutes
Drug Discovery
Bioinformatics
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genomic and Proteomic Tool company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Smart food logistics provider helps FMCG industries to maintain the quality of foods, such as fruits and vegetables, so that it does not spoil. Smart food logistics companies use wireless temperature sensors that help preserve frozen foods and provide multi-zone monitoring in refrigerated trucks and trailers.
North American market for Genomic and Proteomic Tool is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Genomic and Proteomic Tool is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Genomic and Proteomic Tool in Research Labs and Institutes is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Genomic and Proteomic Tool include 3billion, Inc., Bio-Rad Laboratories, Inc., Lucigen Corp., Macrogen, Inc., Abbott, Thermal Fisher Scientific, Inc., Bio-Synthesis, Inc., GE Healthcare, QIAGEN NV, Novogene Corp., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Genomic and Proteomic Tool, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genomic and Proteomic Tool.
The Genomic and Proteomic Tool market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Genomic and Proteomic Tool market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genomic and Proteomic Tool companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
3billion, Inc.
Bio-Rad Laboratories, Inc.
Lucigen Corp.
Macrogen, Inc.
Abbott
Thermal Fisher Scientific, Inc.
Bio-Synthesis, Inc.
GE Healthcare
QIAGEN NV
Novogene Corp.
Waters Corp.
OriGene Technologies
Takara Bio, Inc.
Vela Diagnostics
Segment by Type
Genomics
Proteomics
Segment by Application
Research Labs and Institutes
Drug Discovery
Bioinformatics
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genomic and Proteomic Tool company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genomic and Proteomic Tool Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Genomics
1.2.3 Proteomics
1.3 Market by Application
1.3.1 Global Genomic and Proteomic Tool Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Research Labs and Institutes
1.3.3 Drug Discovery
1.3.4 Bioinformatics
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genomic and Proteomic Tool Market Perspective (2020-2031)
2.2 Global Genomic and Proteomic Tool Growth Trends by Region
2.2.1 Global Genomic and Proteomic Tool Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Genomic and Proteomic Tool Historic Market Size by Region (2020-2025)
2.2.3 Genomic and Proteomic Tool Forecasted Market Size by Region (2026-2031)
2.3 Genomic and Proteomic Tool Market Dynamics
2.3.1 Genomic and Proteomic Tool Industry Trends
2.3.2 Genomic and Proteomic Tool Market Drivers
2.3.3 Genomic and Proteomic Tool Market Challenges
2.3.4 Genomic and Proteomic Tool Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genomic and Proteomic Tool Players by Revenue
3.1.1 Global Top Genomic and Proteomic Tool Players by Revenue (2020-2025)
3.1.2 Global Genomic and Proteomic Tool Revenue Market Share by Players (2020-2025)
3.2 Global Genomic and Proteomic Tool Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Genomic and Proteomic Tool Revenue
3.4 Global Genomic and Proteomic Tool Market Concentration Ratio
3.4.1 Global Genomic and Proteomic Tool Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genomic and Proteomic Tool Revenue in 2024
3.5 Global Key Players of Genomic and Proteomic Tool Head office and Area Served
3.6 Global Key Players of Genomic and Proteomic Tool, Product and Application
3.7 Global Key Players of Genomic and Proteomic Tool, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Genomic and Proteomic Tool Breakdown Data by Type
4.1 Global Genomic and Proteomic Tool Historic Market Size by Type (2020-2025)
4.2 Global Genomic and Proteomic Tool Forecasted Market Size by Type (2026-2031)
5 Genomic and Proteomic Tool Breakdown Data by Application
5.1 Global Genomic and Proteomic Tool Historic Market Size by Application (2020-2025)
5.2 Global Genomic and Proteomic Tool Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Genomic and Proteomic Tool Market Size (2020-2031)
6.2 North America Genomic and Proteomic Tool Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Genomic and Proteomic Tool Market Size by Country (2020-2025)
6.4 North America Genomic and Proteomic Tool Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genomic and Proteomic Tool Market Size (2020-2031)
7.2 Europe Genomic and Proteomic Tool Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Genomic and Proteomic Tool Market Size by Country (2020-2025)
7.4 Europe Genomic and Proteomic Tool Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genomic and Proteomic Tool Market Size (2020-2031)
8.2 Asia-Pacific Genomic and Proteomic Tool Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Genomic and Proteomic Tool Market Size by Region (2020-2025)
8.4 Asia-Pacific Genomic and Proteomic Tool Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genomic and Proteomic Tool Market Size (2020-2031)
9.2 Latin America Genomic and Proteomic Tool Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Genomic and Proteomic Tool Market Size by Country (2020-2025)
9.4 Latin America Genomic and Proteomic Tool Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genomic and Proteomic Tool Market Size (2020-2031)
10.2 Middle East & Africa Genomic and Proteomic Tool Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Genomic and Proteomic Tool Market Size by Country (2020-2025)
10.4 Middle East & Africa Genomic and Proteomic Tool Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 3billion, Inc.
11.1.1 3billion, Inc. Company Details
11.1.2 3billion, Inc. Business Overview
11.1.3 3billion, Inc. Genomic and Proteomic Tool Introduction
11.1.4 3billion, Inc. Revenue in Genomic and Proteomic Tool Business (2020-2025)
11.1.5 3billion, Inc. Recent Development
11.2 Bio-Rad Laboratories, Inc.
11.2.1 Bio-Rad Laboratories, Inc. Company Details
11.2.2 Bio-Rad Laboratories, Inc. Business Overview
11.2.3 Bio-Rad Laboratories, Inc. Genomic and Proteomic Tool Introduction
11.2.4 Bio-Rad Laboratories, Inc. Revenue in Genomic and Proteomic Tool Business (2020-2025)
11.2.5 Bio-Rad Laboratories, Inc. Recent Development
11.3 Lucigen Corp.
11.3.1 Lucigen Corp. Company Details
11.3.2 Lucigen Corp. Business Overview
11.3.3 Lucigen Corp. Genomic and Proteomic Tool Introduction
11.3.4 Lucigen Corp. Revenue in Genomic and Proteomic Tool Business (2020-2025)
11.3.5 Lucigen Corp. Recent Development
11.4 Macrogen, Inc.
11.4.1 Macrogen, Inc. Company Details
11.4.2 Macrogen, Inc. Business Overview
11.4.3 Macrogen, Inc. Genomic and Proteomic Tool Introduction
11.4.4 Macrogen, Inc. Revenue in Genomic and Proteomic Tool Business (2020-2025)
11.4.5 Macrogen, Inc. Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Genomic and Proteomic Tool Introduction
11.5.4 Abbott Revenue in Genomic and Proteomic Tool Business (2020-2025)
11.5.5 Abbott Recent Development
11.6 Thermal Fisher Scientific, Inc.
11.6.1 Thermal Fisher Scientific, Inc. Company Details
11.6.2 Thermal Fisher Scientific, Inc. Business Overview
11.6.3 Thermal Fisher Scientific, Inc. Genomic and Proteomic Tool Introduction
11.6.4 Thermal Fisher Scientific, Inc. Revenue in Genomic and Proteomic Tool Business (2020-2025)
11.6.5 Thermal Fisher Scientific, Inc. Recent Development
11.7 Bio-Synthesis, Inc.
11.7.1 Bio-Synthesis, Inc. Company Details
11.7.2 Bio-Synthesis, Inc. Business Overview
11.7.3 Bio-Synthesis, Inc. Genomic and Proteomic Tool Introduction
11.7.4 Bio-Synthesis, Inc. Revenue in Genomic and Proteomic Tool Business (2020-2025)
11.7.5 Bio-Synthesis, Inc. Recent Development
11.8 GE Healthcare
11.8.1 GE Healthcare Company Details
11.8.2 GE Healthcare Business Overview
11.8.3 GE Healthcare Genomic and Proteomic Tool Introduction
11.8.4 GE Healthcare Revenue in Genomic and Proteomic Tool Business (2020-2025)
11.8.5 GE Healthcare Recent Development
11.9 QIAGEN NV
11.9.1 QIAGEN NV Company Details
11.9.2 QIAGEN NV Business Overview
11.9.3 QIAGEN NV Genomic and Proteomic Tool Introduction
11.9.4 QIAGEN NV Revenue in Genomic and Proteomic Tool Business (2020-2025)
11.9.5 QIAGEN NV Recent Development
11.10 Novogene Corp.
11.10.1 Novogene Corp. Company Details
11.10.2 Novogene Corp. Business Overview
11.10.3 Novogene Corp. Genomic and Proteomic Tool Introduction
11.10.4 Novogene Corp. Revenue in Genomic and Proteomic Tool Business (2020-2025)
11.10.5 Novogene Corp. Recent Development
11.11 Waters Corp.
11.11.1 Waters Corp. Company Details
11.11.2 Waters Corp. Business Overview
11.11.3 Waters Corp. Genomic and Proteomic Tool Introduction
11.11.4 Waters Corp. Revenue in Genomic and Proteomic Tool Business (2020-2025)
11.11.5 Waters Corp. Recent Development
11.12 OriGene Technologies
11.12.1 OriGene Technologies Company Details
11.12.2 OriGene Technologies Business Overview
11.12.3 OriGene Technologies Genomic and Proteomic Tool Introduction
11.12.4 OriGene Technologies Revenue in Genomic and Proteomic Tool Business (2020-2025)
11.12.5 OriGene Technologies Recent Development
11.13 Takara Bio, Inc.
11.13.1 Takara Bio, Inc. Company Details
11.13.2 Takara Bio, Inc. Business Overview
11.13.3 Takara Bio, Inc. Genomic and Proteomic Tool Introduction
11.13.4 Takara Bio, Inc. Revenue in Genomic and Proteomic Tool Business (2020-2025)
11.13.5 Takara Bio, Inc. Recent Development
11.14 Vela Diagnostics
11.14.1 Vela Diagnostics Company Details
11.14.2 Vela Diagnostics Business Overview
11.14.3 Vela Diagnostics Genomic and Proteomic Tool Introduction
11.14.4 Vela Diagnostics Revenue in Genomic and Proteomic Tool Business (2020-2025)
11.14.5 Vela Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genomic and Proteomic Tool Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Genomics
1.2.3 Proteomics
1.3 Market by Application
1.3.1 Global Genomic and Proteomic Tool Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Research Labs and Institutes
1.3.3 Drug Discovery
1.3.4 Bioinformatics
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genomic and Proteomic Tool Market Perspective (2020-2031)
2.2 Global Genomic and Proteomic Tool Growth Trends by Region
2.2.1 Global Genomic and Proteomic Tool Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Genomic and Proteomic Tool Historic Market Size by Region (2020-2025)
2.2.3 Genomic and Proteomic Tool Forecasted Market Size by Region (2026-2031)
2.3 Genomic and Proteomic Tool Market Dynamics
2.3.1 Genomic and Proteomic Tool Industry Trends
2.3.2 Genomic and Proteomic Tool Market Drivers
2.3.3 Genomic and Proteomic Tool Market Challenges
2.3.4 Genomic and Proteomic Tool Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genomic and Proteomic Tool Players by Revenue
3.1.1 Global Top Genomic and Proteomic Tool Players by Revenue (2020-2025)
3.1.2 Global Genomic and Proteomic Tool Revenue Market Share by Players (2020-2025)
3.2 Global Genomic and Proteomic Tool Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Genomic and Proteomic Tool Revenue
3.4 Global Genomic and Proteomic Tool Market Concentration Ratio
3.4.1 Global Genomic and Proteomic Tool Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genomic and Proteomic Tool Revenue in 2024
3.5 Global Key Players of Genomic and Proteomic Tool Head office and Area Served
3.6 Global Key Players of Genomic and Proteomic Tool, Product and Application
3.7 Global Key Players of Genomic and Proteomic Tool, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Genomic and Proteomic Tool Breakdown Data by Type
4.1 Global Genomic and Proteomic Tool Historic Market Size by Type (2020-2025)
4.2 Global Genomic and Proteomic Tool Forecasted Market Size by Type (2026-2031)
5 Genomic and Proteomic Tool Breakdown Data by Application
5.1 Global Genomic and Proteomic Tool Historic Market Size by Application (2020-2025)
5.2 Global Genomic and Proteomic Tool Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Genomic and Proteomic Tool Market Size (2020-2031)
6.2 North America Genomic and Proteomic Tool Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Genomic and Proteomic Tool Market Size by Country (2020-2025)
6.4 North America Genomic and Proteomic Tool Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genomic and Proteomic Tool Market Size (2020-2031)
7.2 Europe Genomic and Proteomic Tool Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Genomic and Proteomic Tool Market Size by Country (2020-2025)
7.4 Europe Genomic and Proteomic Tool Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genomic and Proteomic Tool Market Size (2020-2031)
8.2 Asia-Pacific Genomic and Proteomic Tool Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Genomic and Proteomic Tool Market Size by Region (2020-2025)
8.4 Asia-Pacific Genomic and Proteomic Tool Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genomic and Proteomic Tool Market Size (2020-2031)
9.2 Latin America Genomic and Proteomic Tool Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Genomic and Proteomic Tool Market Size by Country (2020-2025)
9.4 Latin America Genomic and Proteomic Tool Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genomic and Proteomic Tool Market Size (2020-2031)
10.2 Middle East & Africa Genomic and Proteomic Tool Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Genomic and Proteomic Tool Market Size by Country (2020-2025)
10.4 Middle East & Africa Genomic and Proteomic Tool Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 3billion, Inc.
11.1.1 3billion, Inc. Company Details
11.1.2 3billion, Inc. Business Overview
11.1.3 3billion, Inc. Genomic and Proteomic Tool Introduction
11.1.4 3billion, Inc. Revenue in Genomic and Proteomic Tool Business (2020-2025)
11.1.5 3billion, Inc. Recent Development
11.2 Bio-Rad Laboratories, Inc.
11.2.1 Bio-Rad Laboratories, Inc. Company Details
11.2.2 Bio-Rad Laboratories, Inc. Business Overview
11.2.3 Bio-Rad Laboratories, Inc. Genomic and Proteomic Tool Introduction
11.2.4 Bio-Rad Laboratories, Inc. Revenue in Genomic and Proteomic Tool Business (2020-2025)
11.2.5 Bio-Rad Laboratories, Inc. Recent Development
11.3 Lucigen Corp.
11.3.1 Lucigen Corp. Company Details
11.3.2 Lucigen Corp. Business Overview
11.3.3 Lucigen Corp. Genomic and Proteomic Tool Introduction
11.3.4 Lucigen Corp. Revenue in Genomic and Proteomic Tool Business (2020-2025)
11.3.5 Lucigen Corp. Recent Development
11.4 Macrogen, Inc.
11.4.1 Macrogen, Inc. Company Details
11.4.2 Macrogen, Inc. Business Overview
11.4.3 Macrogen, Inc. Genomic and Proteomic Tool Introduction
11.4.4 Macrogen, Inc. Revenue in Genomic and Proteomic Tool Business (2020-2025)
11.4.5 Macrogen, Inc. Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Genomic and Proteomic Tool Introduction
11.5.4 Abbott Revenue in Genomic and Proteomic Tool Business (2020-2025)
11.5.5 Abbott Recent Development
11.6 Thermal Fisher Scientific, Inc.
11.6.1 Thermal Fisher Scientific, Inc. Company Details
11.6.2 Thermal Fisher Scientific, Inc. Business Overview
11.6.3 Thermal Fisher Scientific, Inc. Genomic and Proteomic Tool Introduction
11.6.4 Thermal Fisher Scientific, Inc. Revenue in Genomic and Proteomic Tool Business (2020-2025)
11.6.5 Thermal Fisher Scientific, Inc. Recent Development
11.7 Bio-Synthesis, Inc.
11.7.1 Bio-Synthesis, Inc. Company Details
11.7.2 Bio-Synthesis, Inc. Business Overview
11.7.3 Bio-Synthesis, Inc. Genomic and Proteomic Tool Introduction
11.7.4 Bio-Synthesis, Inc. Revenue in Genomic and Proteomic Tool Business (2020-2025)
11.7.5 Bio-Synthesis, Inc. Recent Development
11.8 GE Healthcare
11.8.1 GE Healthcare Company Details
11.8.2 GE Healthcare Business Overview
11.8.3 GE Healthcare Genomic and Proteomic Tool Introduction
11.8.4 GE Healthcare Revenue in Genomic and Proteomic Tool Business (2020-2025)
11.8.5 GE Healthcare Recent Development
11.9 QIAGEN NV
11.9.1 QIAGEN NV Company Details
11.9.2 QIAGEN NV Business Overview
11.9.3 QIAGEN NV Genomic and Proteomic Tool Introduction
11.9.4 QIAGEN NV Revenue in Genomic and Proteomic Tool Business (2020-2025)
11.9.5 QIAGEN NV Recent Development
11.10 Novogene Corp.
11.10.1 Novogene Corp. Company Details
11.10.2 Novogene Corp. Business Overview
11.10.3 Novogene Corp. Genomic and Proteomic Tool Introduction
11.10.4 Novogene Corp. Revenue in Genomic and Proteomic Tool Business (2020-2025)
11.10.5 Novogene Corp. Recent Development
11.11 Waters Corp.
11.11.1 Waters Corp. Company Details
11.11.2 Waters Corp. Business Overview
11.11.3 Waters Corp. Genomic and Proteomic Tool Introduction
11.11.4 Waters Corp. Revenue in Genomic and Proteomic Tool Business (2020-2025)
11.11.5 Waters Corp. Recent Development
11.12 OriGene Technologies
11.12.1 OriGene Technologies Company Details
11.12.2 OriGene Technologies Business Overview
11.12.3 OriGene Technologies Genomic and Proteomic Tool Introduction
11.12.4 OriGene Technologies Revenue in Genomic and Proteomic Tool Business (2020-2025)
11.12.5 OriGene Technologies Recent Development
11.13 Takara Bio, Inc.
11.13.1 Takara Bio, Inc. Company Details
11.13.2 Takara Bio, Inc. Business Overview
11.13.3 Takara Bio, Inc. Genomic and Proteomic Tool Introduction
11.13.4 Takara Bio, Inc. Revenue in Genomic and Proteomic Tool Business (2020-2025)
11.13.5 Takara Bio, Inc. Recent Development
11.14 Vela Diagnostics
11.14.1 Vela Diagnostics Company Details
11.14.2 Vela Diagnostics Business Overview
11.14.3 Vela Diagnostics Genomic and Proteomic Tool Introduction
11.14.4 Vela Diagnostics Revenue in Genomic and Proteomic Tool Business (2020-2025)
11.14.5 Vela Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Genomic and Proteomic Tool Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Genomics
Table 3. Key Players of Proteomics
Table 4. Global Genomic and Proteomic Tool Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Genomic and Proteomic Tool Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Genomic and Proteomic Tool Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Genomic and Proteomic Tool Market Share by Region (2020-2025)
Table 8. Global Genomic and Proteomic Tool Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Genomic and Proteomic Tool Market Share by Region (2026-2031)
Table 10. Genomic and Proteomic Tool Market Trends
Table 11. Genomic and Proteomic Tool Market Drivers
Table 12. Genomic and Proteomic Tool Market Challenges
Table 13. Genomic and Proteomic Tool Market Restraints
Table 14. Global Genomic and Proteomic Tool Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Genomic and Proteomic Tool Market Share by Players (2020-2025)
Table 16. Global Top Genomic and Proteomic Tool Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomic and Proteomic Tool as of 2024)
Table 17. Ranking of Global Top Genomic and Proteomic Tool Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Genomic and Proteomic Tool Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Genomic and Proteomic Tool, Headquarters and Area Served
Table 20. Global Key Players of Genomic and Proteomic Tool, Product and Application
Table 21. Global Key Players of Genomic and Proteomic Tool, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Genomic and Proteomic Tool Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Genomic and Proteomic Tool Revenue Market Share by Type (2020-2025)
Table 25. Global Genomic and Proteomic Tool Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Genomic and Proteomic Tool Revenue Market Share by Type (2026-2031)
Table 27. Global Genomic and Proteomic Tool Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Genomic and Proteomic Tool Revenue Market Share by Application (2020-2025)
Table 29. Global Genomic and Proteomic Tool Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Genomic and Proteomic Tool Revenue Market Share by Application (2026-2031)
Table 31. North America Genomic and Proteomic Tool Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Genomic and Proteomic Tool Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Genomic and Proteomic Tool Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Genomic and Proteomic Tool Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Genomic and Proteomic Tool Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Genomic and Proteomic Tool Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Genomic and Proteomic Tool Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Genomic and Proteomic Tool Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Genomic and Proteomic Tool Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Genomic and Proteomic Tool Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Genomic and Proteomic Tool Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Genomic and Proteomic Tool Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Genomic and Proteomic Tool Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Genomic and Proteomic Tool Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Genomic and Proteomic Tool Market Size by Country (2026-2031) & (US$ Million)
Table 46. 3billion, Inc. Company Details
Table 47. 3billion, Inc. Business Overview
Table 48. 3billion, Inc. Genomic and Proteomic Tool Product
Table 49. 3billion, Inc. Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)
Table 50. 3billion, Inc. Recent Development
Table 51. Bio-Rad Laboratories, Inc. Company Details
Table 52. Bio-Rad Laboratories, Inc. Business Overview
Table 53. Bio-Rad Laboratories, Inc. Genomic and Proteomic Tool Product
Table 54. Bio-Rad Laboratories, Inc. Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)
Table 55. Bio-Rad Laboratories, Inc. Recent Development
Table 56. Lucigen Corp. Company Details
Table 57. Lucigen Corp. Business Overview
Table 58. Lucigen Corp. Genomic and Proteomic Tool Product
Table 59. Lucigen Corp. Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)
Table 60. Lucigen Corp. Recent Development
Table 61. Macrogen, Inc. Company Details
Table 62. Macrogen, Inc. Business Overview
Table 63. Macrogen, Inc. Genomic and Proteomic Tool Product
Table 64. Macrogen, Inc. Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)
Table 65. Macrogen, Inc. Recent Development
Table 66. Abbott Company Details
Table 67. Abbott Business Overview
Table 68. Abbott Genomic and Proteomic Tool Product
Table 69. Abbott Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)
Table 70. Abbott Recent Development
Table 71. Thermal Fisher Scientific, Inc. Company Details
Table 72. Thermal Fisher Scientific, Inc. Business Overview
Table 73. Thermal Fisher Scientific, Inc. Genomic and Proteomic Tool Product
Table 74. Thermal Fisher Scientific, Inc. Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)
Table 75. Thermal Fisher Scientific, Inc. Recent Development
Table 76. Bio-Synthesis, Inc. Company Details
Table 77. Bio-Synthesis, Inc. Business Overview
Table 78. Bio-Synthesis, Inc. Genomic and Proteomic Tool Product
Table 79. Bio-Synthesis, Inc. Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)
Table 80. Bio-Synthesis, Inc. Recent Development
Table 81. GE Healthcare Company Details
Table 82. GE Healthcare Business Overview
Table 83. GE Healthcare Genomic and Proteomic Tool Product
Table 84. GE Healthcare Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)
Table 85. GE Healthcare Recent Development
Table 86. QIAGEN NV Company Details
Table 87. QIAGEN NV Business Overview
Table 88. QIAGEN NV Genomic and Proteomic Tool Product
Table 89. QIAGEN NV Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)
Table 90. QIAGEN NV Recent Development
Table 91. Novogene Corp. Company Details
Table 92. Novogene Corp. Business Overview
Table 93. Novogene Corp. Genomic and Proteomic Tool Product
Table 94. Novogene Corp. Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)
Table 95. Novogene Corp. Recent Development
Table 96. Waters Corp. Company Details
Table 97. Waters Corp. Business Overview
Table 98. Waters Corp. Genomic and Proteomic Tool Product
Table 99. Waters Corp. Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)
Table 100. Waters Corp. Recent Development
Table 101. OriGene Technologies Company Details
Table 102. OriGene Technologies Business Overview
Table 103. OriGene Technologies Genomic and Proteomic Tool Product
Table 104. OriGene Technologies Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)
Table 105. OriGene Technologies Recent Development
Table 106. Takara Bio, Inc. Company Details
Table 107. Takara Bio, Inc. Business Overview
Table 108. Takara Bio, Inc. Genomic and Proteomic Tool Product
Table 109. Takara Bio, Inc. Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)
Table 110. Takara Bio, Inc. Recent Development
Table 111. Vela Diagnostics Company Details
Table 112. Vela Diagnostics Business Overview
Table 113. Vela Diagnostics Genomic and Proteomic Tool Product
Table 114. Vela Diagnostics Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)
Table 115. Vela Diagnostics Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Genomic and Proteomic Tool Picture
Figure 2. Global Genomic and Proteomic Tool Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Genomic and Proteomic Tool Market Share by Type: 2024 VS 2031
Figure 4. Genomics Features
Figure 5. Proteomics Features
Figure 6. Global Genomic and Proteomic Tool Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Genomic and Proteomic Tool Market Share by Application: 2024 VS 2031
Figure 8. Research Labs and Institutes Case Studies
Figure 9. Drug Discovery Case Studies
Figure 10. Bioinformatics Case Studies
Figure 11. Others Case Studies
Figure 12. Genomic and Proteomic Tool Report Years Considered
Figure 13. Global Genomic and Proteomic Tool Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Genomic and Proteomic Tool Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Genomic and Proteomic Tool Market Share by Region: 2024 VS 2031
Figure 16. Global Genomic and Proteomic Tool Market Share by Players in 2024
Figure 17. Global Top Genomic and Proteomic Tool Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomic and Proteomic Tool as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Genomic and Proteomic Tool Revenue in 2024
Figure 19. North America Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Genomic and Proteomic Tool Market Share by Country (2020-2031)
Figure 21. United States Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Genomic and Proteomic Tool Market Share by Country (2020-2031)
Figure 25. Germany Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Genomic and Proteomic Tool Market Share by Region (2020-2031)
Figure 33. China Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Genomic and Proteomic Tool Market Share by Country (2020-2031)
Figure 41. Mexico Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Genomic and Proteomic Tool Market Share by Country (2020-2031)
Figure 45. Turkey Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. 3billion, Inc. Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)
Figure 49. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)
Figure 50. Lucigen Corp. Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)
Figure 51. Macrogen, Inc. Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)
Figure 52. Abbott Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)
Figure 53. Thermal Fisher Scientific, Inc. Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)
Figure 54. Bio-Synthesis, Inc. Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)
Figure 55. GE Healthcare Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)
Figure 56. QIAGEN NV Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)
Figure 57. Novogene Corp. Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)
Figure 58. Waters Corp. Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)
Figure 59. OriGene Technologies Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)
Figure 60. Takara Bio, Inc. Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)
Figure 61. Vela Diagnostics Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Genomic and Proteomic Tool Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Genomics
Table 3. Key Players of Proteomics
Table 4. Global Genomic and Proteomic Tool Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Genomic and Proteomic Tool Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Genomic and Proteomic Tool Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Genomic and Proteomic Tool Market Share by Region (2020-2025)
Table 8. Global Genomic and Proteomic Tool Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Genomic and Proteomic Tool Market Share by Region (2026-2031)
Table 10. Genomic and Proteomic Tool Market Trends
Table 11. Genomic and Proteomic Tool Market Drivers
Table 12. Genomic and Proteomic Tool Market Challenges
Table 13. Genomic and Proteomic Tool Market Restraints
Table 14. Global Genomic and Proteomic Tool Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Genomic and Proteomic Tool Market Share by Players (2020-2025)
Table 16. Global Top Genomic and Proteomic Tool Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomic and Proteomic Tool as of 2024)
Table 17. Ranking of Global Top Genomic and Proteomic Tool Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Genomic and Proteomic Tool Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Genomic and Proteomic Tool, Headquarters and Area Served
Table 20. Global Key Players of Genomic and Proteomic Tool, Product and Application
Table 21. Global Key Players of Genomic and Proteomic Tool, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Genomic and Proteomic Tool Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Genomic and Proteomic Tool Revenue Market Share by Type (2020-2025)
Table 25. Global Genomic and Proteomic Tool Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Genomic and Proteomic Tool Revenue Market Share by Type (2026-2031)
Table 27. Global Genomic and Proteomic Tool Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Genomic and Proteomic Tool Revenue Market Share by Application (2020-2025)
Table 29. Global Genomic and Proteomic Tool Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Genomic and Proteomic Tool Revenue Market Share by Application (2026-2031)
Table 31. North America Genomic and Proteomic Tool Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Genomic and Proteomic Tool Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Genomic and Proteomic Tool Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Genomic and Proteomic Tool Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Genomic and Proteomic Tool Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Genomic and Proteomic Tool Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Genomic and Proteomic Tool Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Genomic and Proteomic Tool Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Genomic and Proteomic Tool Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Genomic and Proteomic Tool Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Genomic and Proteomic Tool Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Genomic and Proteomic Tool Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Genomic and Proteomic Tool Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Genomic and Proteomic Tool Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Genomic and Proteomic Tool Market Size by Country (2026-2031) & (US$ Million)
Table 46. 3billion, Inc. Company Details
Table 47. 3billion, Inc. Business Overview
Table 48. 3billion, Inc. Genomic and Proteomic Tool Product
Table 49. 3billion, Inc. Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)
Table 50. 3billion, Inc. Recent Development
Table 51. Bio-Rad Laboratories, Inc. Company Details
Table 52. Bio-Rad Laboratories, Inc. Business Overview
Table 53. Bio-Rad Laboratories, Inc. Genomic and Proteomic Tool Product
Table 54. Bio-Rad Laboratories, Inc. Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)
Table 55. Bio-Rad Laboratories, Inc. Recent Development
Table 56. Lucigen Corp. Company Details
Table 57. Lucigen Corp. Business Overview
Table 58. Lucigen Corp. Genomic and Proteomic Tool Product
Table 59. Lucigen Corp. Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)
Table 60. Lucigen Corp. Recent Development
Table 61. Macrogen, Inc. Company Details
Table 62. Macrogen, Inc. Business Overview
Table 63. Macrogen, Inc. Genomic and Proteomic Tool Product
Table 64. Macrogen, Inc. Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)
Table 65. Macrogen, Inc. Recent Development
Table 66. Abbott Company Details
Table 67. Abbott Business Overview
Table 68. Abbott Genomic and Proteomic Tool Product
Table 69. Abbott Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)
Table 70. Abbott Recent Development
Table 71. Thermal Fisher Scientific, Inc. Company Details
Table 72. Thermal Fisher Scientific, Inc. Business Overview
Table 73. Thermal Fisher Scientific, Inc. Genomic and Proteomic Tool Product
Table 74. Thermal Fisher Scientific, Inc. Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)
Table 75. Thermal Fisher Scientific, Inc. Recent Development
Table 76. Bio-Synthesis, Inc. Company Details
Table 77. Bio-Synthesis, Inc. Business Overview
Table 78. Bio-Synthesis, Inc. Genomic and Proteomic Tool Product
Table 79. Bio-Synthesis, Inc. Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)
Table 80. Bio-Synthesis, Inc. Recent Development
Table 81. GE Healthcare Company Details
Table 82. GE Healthcare Business Overview
Table 83. GE Healthcare Genomic and Proteomic Tool Product
Table 84. GE Healthcare Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)
Table 85. GE Healthcare Recent Development
Table 86. QIAGEN NV Company Details
Table 87. QIAGEN NV Business Overview
Table 88. QIAGEN NV Genomic and Proteomic Tool Product
Table 89. QIAGEN NV Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)
Table 90. QIAGEN NV Recent Development
Table 91. Novogene Corp. Company Details
Table 92. Novogene Corp. Business Overview
Table 93. Novogene Corp. Genomic and Proteomic Tool Product
Table 94. Novogene Corp. Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)
Table 95. Novogene Corp. Recent Development
Table 96. Waters Corp. Company Details
Table 97. Waters Corp. Business Overview
Table 98. Waters Corp. Genomic and Proteomic Tool Product
Table 99. Waters Corp. Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)
Table 100. Waters Corp. Recent Development
Table 101. OriGene Technologies Company Details
Table 102. OriGene Technologies Business Overview
Table 103. OriGene Technologies Genomic and Proteomic Tool Product
Table 104. OriGene Technologies Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)
Table 105. OriGene Technologies Recent Development
Table 106. Takara Bio, Inc. Company Details
Table 107. Takara Bio, Inc. Business Overview
Table 108. Takara Bio, Inc. Genomic and Proteomic Tool Product
Table 109. Takara Bio, Inc. Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)
Table 110. Takara Bio, Inc. Recent Development
Table 111. Vela Diagnostics Company Details
Table 112. Vela Diagnostics Business Overview
Table 113. Vela Diagnostics Genomic and Proteomic Tool Product
Table 114. Vela Diagnostics Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)
Table 115. Vela Diagnostics Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Genomic and Proteomic Tool Picture
Figure 2. Global Genomic and Proteomic Tool Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Genomic and Proteomic Tool Market Share by Type: 2024 VS 2031
Figure 4. Genomics Features
Figure 5. Proteomics Features
Figure 6. Global Genomic and Proteomic Tool Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Genomic and Proteomic Tool Market Share by Application: 2024 VS 2031
Figure 8. Research Labs and Institutes Case Studies
Figure 9. Drug Discovery Case Studies
Figure 10. Bioinformatics Case Studies
Figure 11. Others Case Studies
Figure 12. Genomic and Proteomic Tool Report Years Considered
Figure 13. Global Genomic and Proteomic Tool Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Genomic and Proteomic Tool Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Genomic and Proteomic Tool Market Share by Region: 2024 VS 2031
Figure 16. Global Genomic and Proteomic Tool Market Share by Players in 2024
Figure 17. Global Top Genomic and Proteomic Tool Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomic and Proteomic Tool as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Genomic and Proteomic Tool Revenue in 2024
Figure 19. North America Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Genomic and Proteomic Tool Market Share by Country (2020-2031)
Figure 21. United States Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Genomic and Proteomic Tool Market Share by Country (2020-2031)
Figure 25. Germany Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Genomic and Proteomic Tool Market Share by Region (2020-2031)
Figure 33. China Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Genomic and Proteomic Tool Market Share by Country (2020-2031)
Figure 41. Mexico Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Genomic and Proteomic Tool Market Share by Country (2020-2031)
Figure 45. Turkey Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. 3billion, Inc. Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)
Figure 49. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)
Figure 50. Lucigen Corp. Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)
Figure 51. Macrogen, Inc. Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)
Figure 52. Abbott Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)
Figure 53. Thermal Fisher Scientific, Inc. Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)
Figure 54. Bio-Synthesis, Inc. Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)
Figure 55. GE Healthcare Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)
Figure 56. QIAGEN NV Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)
Figure 57. Novogene Corp. Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)
Figure 58. Waters Corp. Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)
Figure 59. OriGene Technologies Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)
Figure 60. Takara Bio, Inc. Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)
Figure 61. Vela Diagnostics Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232